😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Grey Market Premiums Down; Is the IPO Hype Out of Fizz?

Published 12-08-2021, 04:42 pm
Updated 12-08-2021, 04:44 pm
GLEM
-
ROLE
-

By Aditya Raghunath

Investing.com -- The last two weeks have seen grey market premiums (GMPs) for IPOs fall down for stocks by a huge margin. Evidence of this is in the subdued listing of companies like Glenmark Life Sciences Ltd (NS:GLEM) and Rolex Rings Ltd (BO:ROLE).

Glenmark Life Sciences closed day one at Rs 748.5, a premium of less than 4% from its issue price of Rs 720. It had a GMP of Rs 90 so the listing was a pretty big let-down. Likewise, Rolex Rings had a GMP of Rs 480 four days before its listing date but it listed at a 33% premium at Rs 1,200 compared to its issue price of Rs 900. It closed day one at Rs 1,167.

GMP for Devyani International, the largest franchisee for brands like KFC, Pizza Hut and Costa Coffee, has fallen from Rs 75 when the IPO subscription was on to Rs 45 on August 11. Windlas Biotech has seen its IPO fall 50% from Rs 80 to Rs 40. Exxaro Tiles didn’t have a high GMP to begin with, just Rs 14 - Rs 15 and even that has fallen to Rs 8 – Rs 9.

Krsnaa Diagnostics has seen its GMP fall from Rs 435 to Rs 270 while CarTrade Tech has seen a hige fall from Rs 700 to less than Rs 200.

Does this mean the days of huge listing gains are over?

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.